why choose us

First received: January 11, 2023

Clinical Trial: Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients With Post-COVID Syndrome

Study Status: Completed

Recruit Status: RECRUITING

Condition: Long COVID

Study Type: INTERVENTIONAL


Official Title: A Randomized Controlled Phase IIa, Two-arm Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients With Post-COVID Syndrome

Brief Summary: RegeneCyte (HPC, Cord Blood, hUCB) for treatment in patients with post-COVID.

Read more